MY8700745A - 6(r)-(2-8-acyloxy-2'-methyl-6'methyl(or hydrogen)-polyhydronapthyl-1')-ethyl)-4(r)-hydroxy-3,4,5,6-tetrahydro-24-pyran-2-ones, the hydroxy acid from of said pyranones, the parmaceutically acceptable satls of said hydroxy acids, and the lower alkyl, and phenyl, dimethylamino or acetylamino substituted lower alkyl esters of said hydroxy acid, processes for preparing the same, and a parmaceutical antihypercholesterolemic composition containing the same. - Google Patents

6(r)-(2-8-acyloxy-2'-methyl-6'methyl(or hydrogen)-polyhydronapthyl-1')-ethyl)-4(r)-hydroxy-3,4,5,6-tetrahydro-24-pyran-2-ones, the hydroxy acid from of said pyranones, the parmaceutically acceptable satls of said hydroxy acids, and the lower alkyl, and phenyl, dimethylamino or acetylamino substituted lower alkyl esters of said hydroxy acid, processes for preparing the same, and a parmaceutical antihypercholesterolemic composition containing the same.

Info

Publication number
MY8700745A
MY8700745A MY745/87A MY8700745A MY8700745A MY 8700745 A MY8700745 A MY 8700745A MY 745/87 A MY745/87 A MY 745/87A MY 8700745 A MY8700745 A MY 8700745A MY 8700745 A MY8700745 A MY 8700745A
Authority
MY
Malaysia
Prior art keywords
hydroxy
methyl
lower alkyl
same
hydroxy acid
Prior art date
Application number
MY745/87A
Other languages
English (en)
Inventor
Alvin K William
Robert L Smith
William F Hoffmann
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27494171&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MY8700745(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/175,232 external-priority patent/US4293496A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of MY8700745A publication Critical patent/MY8700745A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Steroid Compounds (AREA)
MY745/87A 1980-02-04 1987-12-30 6(r)-(2-8-acyloxy-2'-methyl-6'methyl(or hydrogen)-polyhydronapthyl-1')-ethyl)-4(r)-hydroxy-3,4,5,6-tetrahydro-24-pyran-2-ones, the hydroxy acid from of said pyranones, the parmaceutically acceptable satls of said hydroxy acids, and the lower alkyl, and phenyl, dimethylamino or acetylamino substituted lower alkyl esters of said hydroxy acid, processes for preparing the same, and a parmaceutical antihypercholesterolemic composition containing the same. MY8700745A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11805180A 1980-02-04 1980-02-04
US11804980A 1980-02-04 1980-02-04
US17546080A 1980-08-05 1980-08-05
US06/175,232 US4293496A (en) 1980-02-04 1980-08-05 6(R)-[2-(8-Hydroxy-2,6-dimethylpolyhydronaphthyl-1)-ethyl]-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-ones

Publications (1)

Publication Number Publication Date
MY8700745A true MY8700745A (en) 1987-12-31

Family

ID=27494171

Family Applications (1)

Application Number Title Priority Date Filing Date
MY745/87A MY8700745A (en) 1980-02-04 1987-12-30 6(r)-(2-8-acyloxy-2'-methyl-6'methyl(or hydrogen)-polyhydronapthyl-1')-ethyl)-4(r)-hydroxy-3,4,5,6-tetrahydro-24-pyran-2-ones, the hydroxy acid from of said pyranones, the parmaceutically acceptable satls of said hydroxy acids, and the lower alkyl, and phenyl, dimethylamino or acetylamino substituted lower alkyl esters of said hydroxy acid, processes for preparing the same, and a parmaceutical antihypercholesterolemic composition containing the same.

Country Status (22)

Country Link
EP (1) EP0033538B1 (2)
AU (1) AU548996B2 (2)
CA (1) CA1199322A (2)
CY (1) CY1404A (2)
DD (1) DD155989A5 (2)
DE (1) DE3173042D1 (2)
DK (1) DK157292C (2)
ES (1) ES8609296A1 (2)
FI (1) FI78082C (2)
GR (1) GR74798B (2)
HK (1) HK16488A (2)
IE (1) IE51478B1 (2)
IL (1) IL62044A (2)
MA (1) MA19054A1 (2)
MY (1) MY8700745A (2)
NL (1) NL930009I2 (2)
NO (2) NO154229C (2)
NZ (1) NZ196172A (2)
PT (1) PT72441B (2)
RO (1) RO82367B (2)
SG (1) SG61087G (2)
YU (1) YU28181A (2)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0692381B2 (ja) * 1980-03-31 1994-11-16 三共株式会社 Ｍｂ−５３０ａ誘導体
US4432996A (en) * 1980-11-17 1984-02-21 Merck & Co., Inc. Hypocholesterolemic fermentation products and process of preparation
US4343814A (en) * 1980-11-17 1982-08-10 Merck & Co., Inc. Hypocholesterolemic fermentation products
EP0094443A1 (en) * 1982-05-17 1983-11-23 Merck & Co. Inc. 6(R)-(2-(8(S) (2,2-dimethylbutyryloxy)-2(S),6(S)-dimethyl-1,2,3,4,4a(S),5,6,7,8,8a(S)-decahydronaphthyl-1(S))ethyl)-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one, process for preparing and pharmaceutical composition containing the same
US4503072A (en) * 1982-12-22 1985-03-05 Merck & Co., Inc. Antihypercholesterolemic compounds
DE3461180D1 (en) * 1983-01-24 1986-12-11 Sandoz Ag Analogs of mevalonolactone and derivatives thereof, processes for their production, pharmaceutical compositions containing them and their use as pharmaceuticals
DE3480923D1 (de) * 1983-10-11 1990-02-08 Merck & Co Inc Verfahren zur c-methylierung von 2-methylbutyraten.
EP0137444B1 (en) * 1983-10-11 1990-01-31 Merck & Co. Inc. Processes for preparing 6(R)-[2-[8(S)(2,2-dimethylbutyryloxy)-2(S),6(S)-dimethyl-1,2,3,4,4a(S),5,6,7,8,8a(S)-Decahydronaphthyl-1(S)]ethyl]-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one
US4668699A (en) * 1985-08-05 1987-05-26 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US4833258A (en) * 1987-02-17 1989-05-23 Merck & Co., Inc. Intermediates useful in the preparation of HMG-COA reductase inhibitors
US4997848A (en) 1987-10-27 1991-03-05 Sankyo Company, Limited Octahydronaphthalene oxime derivatives for cholesterol synthesis inhibition
US5021451A (en) * 1988-11-14 1991-06-04 Hoffman-La Roche Inc. Method for inhibiting hyperproliferative diseases
GB8915280D0 (en) * 1989-07-04 1989-08-23 British Bio Technology Compounds
US5110825A (en) * 1989-12-28 1992-05-05 Shionogi & Co., Ltd. Benzofuran derivative
GB9100174D0 (en) * 1991-01-04 1991-02-20 British Bio Technology Compounds
NZ250609A (en) * 1992-12-28 1995-07-26 Sankyo Co Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments
US6268392B1 (en) 1994-09-13 2001-07-31 G. D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
US6642268B2 (en) 1994-09-13 2003-11-04 G.D. Searle & Co. Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
US5798375A (en) * 1995-07-03 1998-08-25 Sankyo Company, Limited Treatment of arteriosclerosis and xanthoma
AU7271696A (en) * 1995-12-06 1997-06-27 Antibiotic Co Method of production of lovastatin
CA2185961A1 (en) 1996-09-19 1998-03-20 K.S. Keshava Murthy Process for producing simvastatin
US6083497A (en) 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
SI9800057A (sl) * 1998-02-26 1999-08-31 Krka, Tovarna Zdravil, D.D. Postopek za pripravo simvastatina in njegovih derivatov
CA2240983A1 (en) 1998-06-18 1999-12-18 Yong Tao Process to manufacture simvastatin and intermediates
JP2002533410A (ja) 1998-12-23 2002-10-08 ジー．ディー．サール エルエルシー 心臓血管に適用するためのコレステリルエステル転送タンパク質阻害剤およびフィブリン酸誘導体の組み合わせ
EP1340510A1 (en) 1998-12-23 2003-09-03 G.D. Searle LLC. Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
PL348508A1 (en) 1998-12-23 2002-05-20 Searle Llc Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indications
AU2157400A (en) 1998-12-23 2000-07-31 G.D. Searle & Co. Combinations of cholesteryl ester transfer protein inhibitors and hmg coa reductase inhibitors for cardiovascular indications
US6489366B1 (en) 1998-12-23 2002-12-03 G. D. Searle, Llc Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications
CN1342090A (zh) 1998-12-23 2002-03-27 G·D·瑟尔有限公司 适用于心血管疾病的回肠胆汁酸转运抑制剂和贝酸衍生物的组合
JP2002533414A (ja) 1998-12-23 2002-10-08 ジー．ディー．サール エルエルシー 心臓血管に適用するための回腸胆汁酸輸送阻害剤および胆汁酸隔離剤の組み合わせ
WO2001068637A2 (en) 2000-03-10 2001-09-20 Pharmacia Corporation Method for the preparation of tetrahydrobenzothiepines
JP4870320B2 (ja) * 2000-09-07 2012-02-08 株式会社カネカ ヒドロキシカルボン酸の結晶化法
MXPA04003524A (es) 2001-11-02 2004-07-23 Searle Llc Compuestos de benzotiepina monofluorados y difluorados novedosos como inhibidores de transporte de acido biliar co-dependiente de sodio apical (asbt) y captacion de taurocolato.
BR0306643A (pt) 2002-01-17 2004-10-19 Pharmacia Corp Novos compostos de hidroxi alquil/aril ou ceto tiepina como inibidores do transporte co-dependente de ácido biliar-sódio apical
SI21187A (sl) 2002-03-26 2003-10-31 Krka, Tovarna Zdravil D.D., Novo Mesto Postopek za pripravo 4-oksitetrahidropiran-2-onov
KR20040092790A (ko) * 2003-04-29 2004-11-04 씨제이 주식회사 심바스타틴 중간체 제조방법
EP1741427A1 (en) 2005-07-06 2007-01-10 KRKA, D.D., Novo Mesto Pharmaceutical composition comprising simvastatin and ezetimibe
EP2359826B1 (en) 2006-07-05 2013-10-30 Takeda GmbH Combination of HMG-COA reductase inhibitor rosuvastatin with a phosphodiesterase 4 inhibitor, such as roflumilast, roflumilast-N-oxide for the treatment of inflammatory pulmonary diseases
WO2009013764A2 (en) * 2007-07-24 2009-01-29 Jubilant Organosys Limited Process for producing 6(r)-[2-(8'(s)-2 ',2 '-dimethylbutyryloxy-2'(s),6'(r)-dimethyl-1,2,6,7', 8',8a'(r)- hexahydronaphthyl-l'(s))ethyl]-4(r)-hydroxy-3,4,5,6- tetrahydro-2h-pyran-2-one
JOP20080381B1 (ar) 2007-08-23 2023-03-28 Amgen Inc بروتينات مرتبطة بمولدات مضادات تتفاعل مع بروبروتين كونفيرتاز سيتيليزين ككسين من النوع 9 (pcsk9)
ES2330184B1 (es) 2008-06-03 2010-07-05 Neuron Biopharma, S.A. Uso de estatinas como anticonvulsivantes, antiepilepticos y neuroprotectores.
ES2343049B1 (es) 2008-10-15 2011-06-10 Neuron Biopharma, S.A. Biosintesis de derivados de monacolina j.
EP2204170A1 (en) 2008-12-01 2010-07-07 LEK Pharmaceuticals D.D. Pharmaceutical composition comprising ezetimibe and simvastatin
EP2327682A1 (en) 2009-10-29 2011-06-01 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
WO2010069593A1 (en) 2008-12-19 2010-06-24 Krka, D. D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
EP2216016A1 (en) 2009-02-06 2010-08-11 LEK Pharmaceuticals d.d. Process for the preparation of a pharmaceutical composition comprising ezetimibe
EP2241561A1 (en) * 2009-04-16 2010-10-20 Neuron Biopharma, S.A. Neuroprotective, hypocholesterolemic and antiepileptic compound
WO2011002424A2 (en) 2009-07-02 2011-01-06 Bilgic Mahmut Solubility and stability enchancing pharmaceutical formulation
AR079336A1 (es) 2009-12-11 2012-01-18 Irm Llc Antagonistas de la pro-proteina convertasa-subtilisina/quexina tipo 9 (pcsk9)
EP2368543A1 (en) 2010-03-25 2011-09-28 KRKA, tovarna zdravil, d.d., Novo mesto Method of preparing a granulated pharmaceutical composition comprising simvastatin and/or ezetimibe
ES2380473B1 (es) * 2010-10-13 2013-02-19 Neuron Biopharma, S.A. Compuesto neuroprotector, hipocolesterolémico, antiinflamatorio y antiepiléptico.
JOP20200043A1 (ar) 2011-05-10 2017-06-16 Amgen Inc طرق معالجة أو منع الاضطرابات المختصة بالكوليسترول
BR112014016154A8 (pt) 2011-12-29 2017-07-04 Tufts College funcionalização de biomateriais para controlar respostas à regeneração e inflamação
EP2861624A1 (en) 2012-06-15 2015-04-22 F. Hoffmann-La Roche AG Anti-pcsk9 antibodies, formulations, dosing, and methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5612114B2 (2) * 1974-06-07 1981-03-18
US4049495A (en) * 1974-06-07 1977-09-20 Sankyo Company Limited Physiologically active substances and fermentative process for producing the same
US4137322A (en) 1976-11-02 1979-01-30 Sankyo Company Limited ML-236B carboxylic acid derivatives and their use as antihyperlipemic agents
JPS6026094B2 (ja) 1978-07-04 1985-06-21 三共株式会社 テトラヒドロｍｌ↓−２３６ｂおよびその誘導体並びにそれを有効成分とする高脂血症治療剤
JPS5925599B2 (ja) * 1979-02-20 1984-06-19 三共株式会社 新生理活性物質モナコリンｋおよびその製造法
US4231938A (en) * 1979-06-15 1980-11-04 Merck & Co., Inc. Hypocholesteremic fermentation products and process of preparation
IL60219A (en) * 1979-06-15 1985-05-31 Merck & Co Inc Hypocholesteremic fermentation products of the hmg-coa reductase inhibitor type,their preparation and pharmaceutical compositions containing them
PT72394B (en) 1980-02-04 1982-09-06 Merck & Co Inc Process for preparing dihydro and tetrahydromevinoline hypocholesterolimics

Also Published As

Publication number Publication date
DD155989A5 (de) 1982-07-21
IL62044A (en) 1987-03-31
FI78082B (fi) 1989-02-28
DE3173042D1 (en) 1986-01-09
YU28181A (en) 1983-10-31
AU548996B2 (en) 1986-01-09
MA19054A1 (fr) 1981-10-01
RO82367B (ro) 1984-02-28
FI810287L (fi) 1981-08-05
SG61087G (en) 1987-10-23
NZ196172A (en) 1985-01-31
PT72441B (pt) 1984-08-01
EP0033538A2 (en) 1981-08-12
AU6657381A (en) 1981-08-13
CA1199322A (en) 1986-01-14
EP0033538A3 (en) 1982-02-24
ES499079A0 (es) 1985-10-16
RO82367A (ro) 1984-02-21
FI78082C (fi) 1989-06-12
DK157292C (da) 1990-05-07
PT72441A (pt) 1981-03-01
HK16488A (en) 1988-03-11
ES8609296A1 (es) 1985-10-16
NO810358L (no) 1981-08-05
NO1994001I1 (no) 1994-07-01
IE51478B1 (en) 1987-01-07
NO154229B (no) 1986-05-05
GR74798B (2) 1984-07-12
IL62044A0 (en) 1981-03-31
NL930009I1 (nl) 1993-04-01
NO154229C (no) 1986-08-13
NL930009I2 (nl) 1993-09-16
IE810204L (en) 1981-08-04
DK46181A (da) 1981-08-05
DK157292B (da) 1989-12-04
EP0033538B1 (en) 1985-11-27
CY1404A (en) 1988-04-22

Similar Documents

Publication Publication Date Title
MY8700745A (en) 6(r)-(2-8-acyloxy-2'-methyl-6'methyl(or hydrogen)-polyhydronapthyl-1')-ethyl)-4(r)-hydroxy-3,4,5,6-tetrahydro-24-pyran-2-ones, the hydroxy acid from of said pyranones, the parmaceutically acceptable satls of said hydroxy acids, and the lower alkyl, and phenyl, dimethylamino or acetylamino substituted lower alkyl esters of said hydroxy acid, processes for preparing the same, and a parmaceutical antihypercholesterolemic composition containing the same.
EP0033536A3 (en) 6(r)-(2-(8'-etherified-hydroxy-2',6'-dimethylpolyhydro-naphthyl-1')-ethyl)-4(r)-hydroxy-3,4,5,6-tetrahydro-2h-pyran-2-ones, the hydroxy acid form of said pyranones, the salts and esters of said acid form, process for preparing the same and an antihypercholesterolemic pharmaceutical composition containing the same
TW260673B (2)
JPS549269A (en) Carboxylic acid esters, process for their preparation and insecticides and miticides containing the same as active constituents
ZA983047B (en) An oleonsin 5' regulatory region for the modification of plant seed lipid composition
GR3035089T3 (en) Analogs of pth.
EP0582931A3 (en) Process for the continuous preparation of diarylcarbonates from dialkylcarbonates
HUT52025A (en) Insecticide compositions containing cyclopropyl-substituted diaryl compounds as active component and process for producing the active components
EP0484769A3 (en) Improved process for crystallizing l-alpha-aspartyl-l-phenylalanine methyl ester from the solution
FR2676042B1 (fr) Procede de preparation d'un borohydrure de metal alcalin tel que le borohydrure de lithium.
KE3746A (en) 6(r)-(2-(8'-acyloxy-2'-methyl-6'-methyl(or hydrogen)-polyhydronaphthyl-1')-ethyl)-4(r)-hydroxy-3,4,5,6-tetrahydro-2h-pyran-2-ones,the hydroxy acid form of said pyranones,the pharmaceutically acceptable salts of said hydroxy acids,and the lower alkyl,and phenyl,dimethylamino or acetylamino substituted lower alkyl esters of said hydroxy acid,processes for preparing the same, and a pharmaceutical antihypercholesterolemic composition containing the same
IL101719A (en) Liquid refrigerant compositions containing complex carboxylic esters as lubricant
EP0137444A3 (en) Processes for preparing 6(r)-û2-û8(s)(2,2-dimethylbutyryloxy)-2(s),6(s)-dimethyl-1,2,3,4,4a(s),5,6,7,8,8a(s)-decahydronaphthyl-1(s)¨ethyl¨-4(r)-hydroxy-3,4,5,6-tetrahydro-2h-pyran-2-one
AU646436B2 (en) Processes for preparing 2-halogeno-3-hydroxy-3- phenylpropionic acid ester compounds
EP0558012A3 (en) Method for the manufacture of branched polysiloxane
ITMI921784A1 (it) Procedimento per l'allontanamento dei componenti volatili da soluzioni contenenti polifenileneteri
ATE105277T1 (de) Verfahren zur racemisierung von optisch aktiven 4-phenylbuttersaeureestern.
NO931532D0 (no) Vaeskesammensetninger som inneholder karboksylsyreestere
EP0554844A3 (en) Process for the preparation of esters of omega (o-substituted urethane)alkylcarboxylic acids
EP0560158A3 (en) Process for the preparation of beta-aminoacrylic acid esters
DE3362750D1 (en) Process for preparing alpha,omega-bis(2-chlorophenoxy)-alkane-4,4'-dicarboxylic acid or its lower alkyl ester
EP0473020A3 (en) Process for the preparation of alkali metal salts of 2-phosphonobutane-1,2,4-tricarboxylic acid
JPS55145664A (en) Dihydroindole derivative
JPS5386034A (en) Insecticides and miticides containing novel cyclopropanecarboxylic acid esters and process for their preparation
PL267947A1 (en) Method for removal of unsaturated compounds from 1,2-dichlorethane